New Dual-Target Vaccine Shows Promise Against Typhoid and Salmonella
The Phase 1 trial showed 100% of vaccine recipients developed strong immune responses with mild side effects, addressing 1.35 million US Salmonella infections annually.
4 Articles
4 Articles
New dual-target vaccine shows promise against typhoid and Salmonella
Researchers at the University of Maryland School of Medicine's Center for Vaccine Development and Global Health (CVD) have completed a successful Phase 1 clinical trial of a novel vaccine designed to protect against both typhoid fever and invasive non-typhoidal Salmonella--two major causes of illness and death among children in sub-Saharan Africa.
Vaccine shows promise against typhoid and invasive Salmonella in first human trial
Researchers at the University of Maryland School of Medicine's Center for Vaccine Development and Global Health (CVD) have completed a successful Phase I clinical trial of a novel vaccine designed to protect against both typhoid fever and invasive non-typhoidal Salmonella—two major causes of illness and death among children in sub-Saharan Africa.
New Vaccine Demonstrates Potential Against Typhoid and Invasive Salmonella
In a groundbreaking advancement for global health, researchers at the University of Maryland School of Medicine’s Center for Vaccine Development and Global Health (CVD) have announced the successful completion of a Phase 1 clinical trial for an innovative vaccine targeting two of the most devastating bacterial infections affecting children in sub-Saharan Africa: typhoid fever and […]
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium